Product NDC: | 0409-0144 |
Proprietary Name: | Azithromycin |
Non Proprietary Name: | AZITHROMYCIN MONOHYDRATE |
Active Ingredient(s): | 500 mg/1 & nbsp; AZITHROMYCIN MONOHYDRATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-0144 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065500 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090626 |
Package NDC: | 0409-0144-11 |
Package Description: | 10 VIAL, SINGLE-USE in 1 TRAY (0409-0144-11) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
NDC Code | 0409-0144-11 |
Proprietary Name | Azithromycin |
Package Description | 10 VIAL, SINGLE-USE in 1 TRAY (0409-0144-11) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
Product NDC | 0409-0144 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | AZITHROMYCIN MONOHYDRATE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090626 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | AZITHROMYCIN MONOHYDRATE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |